SHA:600056

2 stories mentioning SHA:600056Updated just now

Every FINWIRES story that references SHA:600056, newest first.

Meheco's Eight Drugs Recommended for China's Centralized Procurement List

China Meheco Group (SHA:600056) said eight of its drugs were proposed to be selected for the twelfth round of China's National Centralized Drug Procurement, according to a Shanghai bourse filing on Tuesday.The drugs, which were all produced by the company's subsidiaries, are betahistine hydrochloride tablets, vonoprazan fumarate tablets, vitamin B6 injection, sacubitril/valsartan sodium tablets, isavuconazole sulfate for injection, edoxaban tosylate tablets, carbazochrome sodium sulfonate injection and valacyclovir hydrochloride tablets.

SHA:600056

Asia47d ago

Meheco Says Diclofenac Sodium Tablets Pass Chinese Drug Regulator's Consistency Evaluation

China Meheco Group's (SHA:600056) unit, Tianfang Pharmaceutical, received approval from China's National Medical Products Administration for its supplemental drug application for diclofenac sodium enteric-coated tablets after passing the regulator's consistency evaluation, according to a Shanghai bourse filing on Thursday.The evaluation tested the drug's quality and efficacy.The drug is mainly used for the treatment of inflammatory and degenerative rheumatic diseases, various rheumatic pain and gout.

SHA:600056

Track with the FINWIRES app suite

FolioX

Track SHA:600056 in your portfolio

WheelAI

Analyze SHA:600056 options with the wheel strategy

StockInsider

See market sentiment on SHA:600056